Antithrombotic therapy in patients with atrialfibrillation after percutaneous coronary stenting:between scylla and charybdis

Authors: Shpektor A.V.

Company: Cardiology Chair of Moscow State University of Medicine and Dentistry named after A.I. Evdokimov of Ministry of Health of the Russian Federation; Delegatskaya ulitsa, 20/1, Moscow, 127473, Russian Federation

For correspondence:  Sign in or register.


DOI: https://doi.org/10.15275/kreatkard.2017.01.01

For citation: Shpektor A.V. Antithrombotic therapy in patients with atrial fibrillation after percutaneous coronary stenting: between Scylla and Charybdis. Kreativnaya kardiologiya (Creative Cardiology, Russian journal). 2017; 11 (1): 5–7 (in Russ.). DOI: 10.15275/kreatkard.2017.01.01

Received / Accepted:  March 07, 2017 / March 15, 2017

Download
Full text:  

 

References

  1. Kirchhof P., Benussi S., Kotecha D. et al. ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur. Heart J. 2016; 37 (38): 2893–962.

  2. Dewilde W.J., Oirbans T., Verheuqt F.W. et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an openlabel, randomised, controlled trial. Lancet. 2013; 381 (9872): 1107–15.

  3. Gibson C.M., Mehran R., Bode C. et al. An open label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI). Am. Heart J. 2015; 169 (4): 472–8.

  4. Gibson C.M., Pinto D.S., Chi G. et al. Recurrent hospitalization among patients with atrial fibrillation undergoing intracoronary stenting treated with 2 treatment strategies of rivaroxaban or a doseadjusted oral vitamin k antagonist treatment strategy. Circulation. 2017; 135 (4): 323–33.

About Authors

Shpektor Aleksandr Vadimovich, MD, DM, Professor, Chief of Chair

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery